This study was partially supported by a grant from the Scientific Research Fund for Capital Medicine Development (No.ZD 199911).
It is well-known that risk for endometrial adenocarcinoma increases in patients with high level ofestrogen that is unopposed by progestin. And activation of extracellular signal-regulated kinase (ERK) and phosphatid...